Publications
Filters: Author is Carrato, A [Clear All Filters]
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36. Abstract
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer. 2010;103(4):581-9. Abstract
Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30. Abstract
Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9. Abstract
Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41. Abstract
